Metabolic Psychiatry: The Science of Hope - MD Ede
Dr. Ede is a Harvard-trained psychiatrist and a pioneer in nutritional and metabolic psychiatry. With over two decades of clinical experience, she explores how dietary strategies—especially low-carb and ketogenic therapies—can profoundly impact mental health.
In this powerful session, Dr. Ede unpacks the science behind metabolic psychiatry and why it offers real hope for patients and practitioners alike.
::: spoiler summerizer Metabolic psychiatry and brain energy
- Metabolic psychiatry adds glucose, insulin, inflammation, oxidative stress, and mitochondrial energy to the older neurotransmitter-centered model of psychiatric illness.
- High glucose and high insulin can drive brain inflammation, oxidative stress, advanced glycation end products, and neurotransmitter disruption.
- Excess inflammation and oxidative stress can push glutamate far above baseline and damage proteins, lipids, DNA, mitochondria, the blood-brain barrier, and the hippocampus.
- Brain glucose entry is insulin independent, but brain glucose use depends on adequate brain insulin.
- Chronic high insulin can make the blood-brain barrier insulin resistant, so the brain can receive too little insulin while glucose remains high.
- Cerebral glucose hypometabolism is the energy deficit that links metabolic dysfunction to late-onset Alzheimer’s disease and serious psychiatric illness.
- Ketones cross into the brain even when insulin resistance is severe and burn well in a low-insulin environment.
- Ketogenic therapy can bridge the brain energy gap when more glucose or more insulin would worsen the metabolic problem.
Clinical evidence and active trials
- Alzheimer’s disease has long-standing metabolic evidence, including the type 3 diabetes model from Brown University and earlier insulin-signaling work.
- Cynthia Calkin’s bipolar depression trial used metformin to reverse insulin resistance, and mood improvement occurred in the patients whose insulin resistance reversed.
- Ketogenic diet research in psychiatry is expanding across bipolar disorder, schizophrenia, depression, alcohol withdrawal, autism, Alzheimer’s disease, ADHD, and anorexia.
- The alcohol-withdrawal randomized trial found that people on a ketogenic diet required about half as much benzodiazepine and had fewer alcohol cravings.
- Albert Danan’s inpatient ketogenic diet analysis involved 31 severe, therapy-resistant patients with depression, bipolar disorder, and schizophrenia.
- In Danan’s adherent inpatient group, all 28 patients improved psychiatrically and metabolically, 43% reached clinical remission, and 64% left on less psychiatric medication.
- Ian Campbell’s bipolar pilot enrolled euthymic outpatients for an 8-week ketogenic diet and found strong adherence, average ketones around 1.3 mmol/L, and symptom links with ketone levels.
- Campbell’s spectroscopy data showed a large reduction in brain glutamate-related signal, with several participants refusing to stop the diet after the protocol ended.
- Shebani Sethi’s Stanford pilot placed outpatients with bipolar disorder or schizophrenia on a ketogenic diet for 4 months and found clinically meaningful psychiatric improvement in most participants.
- Randomized trials are still needed for serious mood and psychotic disorders, and new studies are underway or planned at Oxford, UC San Diego, Stanford, and other sites.
Clinical use and ketone targets
- Psychiatric ketogenic therapy needs clinician oversight when patients have serious symptoms, take psychiatric medications, or have anorexia risk.
- Medication interactions matter because antipsychotics and some anticonvulsants can make ketone production harder.
- For low ketones, insulin is the control knob: lower total carbohydrates, sometimes below 20 g; count total carbs; regulate protein; avoid snacking; and add resistance exercise.
- Whey, casein, dairy excess, sweeteners, frequent eating, and excess protein can keep insulin high even when glucose does not rise.
- A practical starting target is blood ketones between 1.0 and 3.0 mmol/L most of the time.
- Some patients improve with simple low carbohydrate intake and low glucose, while others need sustained ketones in a tighter or higher range.
- A fair trial requires consistent therapeutic ketosis for weeks, not occasional late-day ketone readings.
Q&A applications
- GLP-1 agonists can reduce appetite, glucose, and insulin and may help some patients bridge into ketogenic therapy, but responses can be positive, neutral, or counterproductive.
- Continuous ketone monitors may be most useful for patterns, timing, overnight changes, food responses, and hidden gaps in daily ketosis.
- Gut symptoms matter in psychiatric ketogenic care, and persistent constipation should lead to food-choice review after the adaptation period.
- High-fiber foods, cruciferous vegetables, nuts, seeds, chia, cheese, and dairy can be hard to digest for some patients.
- The quiet diet approach uses paleo, keto, or carnivore versions designed to be gentler on the gut.
- Fiber requirements for the microbiome are cast as untested, and many people with serious gastrointestinal symptoms improve when fiber is reduced.
- Mediterranean-style diet changes can help depression when they replace a junk-food diet, but the metabolic piece may require lower carbohydrate intake.
- Type 1 diabetes makes ketosis harder because injected insulin suppresses ketone production, so exercise and careful monitoring become more important.
- Women may have more difficulty entering ketosis during perimenopause and menopause because falling estrogen can worsen insulin resistance.
- Estrogen replacement may help some women improve metabolic flexibility, while progesterone may push metabolism in the opposite direction.
- Early Alzheimer’s patients who remain hyperglycemic and out of ketosis on low carbohydrate intake may need lower protein and higher fat intake.
References
- [00:01] Change Your Diet, Change Your Mind — https://www.gcp-balance.com/titles/dr-georgia-ede-m-d/change-your-diet-change-your-mind/9781538739075/
- [00:12] Impaired Insulin and Insulin-Like Growth Factor Expression and Signaling Mechanisms in Alzheimer’s Disease – Is This Type 3 Diabetes? — https://doi.org/10.3233/JAD-2005-7107
- [00:13] Alzheimer’s Disease Is Type 3 Diabetes—Evidence Reviewed — https://doi.org/10.1177/193229680800200619
- [00:15] Treating Insulin Resistance With Metformin as a Strategy to Improve Clinical Outcomes in Treatment-Resistant Bipolar Depression (the TRIO-BD Study): A Randomized, Quadruple-Masked, Placebo-Controlled Clinical Trial — https://doi.org/10.4088/JCP.21m14022
- [00:19] Ketogenic Diet Reduces Alcohol Withdrawal Symptoms in Humans and Alcohol Intake in Rodents — https://doi.org/10.1126/sciadv.abf6780
- [00:19] Ketogenic Diet Versus Gluten Free Casein Free Diet in Autistic Children: A Case-Control Study — https://doi.org/10.1007/s11011-017-0088-z
- [00:19] Randomized Crossover Trial of a Modified Ketogenic Diet in Alzheimer’s Disease — https://doi.org/10.1186/s13195-021-00783-x
- [00:22] The Ketogenic Diet for Refractory Mental Illness: A Retrospective Analysis of 31 Inpatients — https://doi.org/10.3389/fpsyt.2022.951376
- [00:25] Pilot Study of a Ketogenic Diet in Bipolar Disorder — https://doi.org/10.1192/bjo.2023.568
- [00:27] A Pilot Study of a Ketogenic Diet in Bipolar Disorder: Clinical, Metabolic and Magnetic Resonance Spectroscopy Findings — https://doi.org/10.1192/bjo.2024.841
- [00:28] Ketogenic Diet Intervention on Metabolic and Psychiatric Health in Bipolar and Schizophrenia: A Pilot Trial — https://doi.org/10.1016/j.psychres.2024.115866
- [00:31] Metabolic Mind — https://www.metabolicmind.org/
- [00:31] Ketogenic Diets for Mental Health Resources — https://www.diagnosisdiet.com/resources
- [00:44] Impact of Glucagon-Like Peptide 1 Agonist Deprescription in Type 2 Diabetes in a Real-World Setting: A Propensity Score Matched Cohort Study — https://doi.org/10.1007/s13300-024-01547-0
- [00:52] The Effects of Ketogenic Metabolic Therapy on Mental Health and Metabolic Outcomes in Schizophrenia and Bipolar Disorder: A Randomized Controlled Clinical Trial Protocol — https://doi.org/10.3389/fnut.2024.1444483
- [01:03] Stress Dynamically Modulates Neuronal Autophagy to Gate Depression Onset — https://doi.org/10.1038/s41586-025-08807-4
- [01:21] Child Bipolar Network Ketogenic Diet Approach to Depression or Mixed Mood in Bipolar Disorder — https://clinicaltrials.gov/study/NCT06920940
- [01:21] Food for ADHD and Depression — https://www.isrctn.com/ISRCTN62698625
- [01:21] Therapeutic Ketogenic Diet in Anorexia Nervosa — https://clinicaltrials.gov/study/NCT06000774 :::
View original on hackertalks.com